These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 28807620)
21. Muscarinic and nicotinic receptors synergistically modulate working memory and attention in humans. Ellis JR; Ellis KA; Bartholomeusz CF; Harrison BJ; Wesnes KA; Erskine FF; Vitetta L; Nathan PJ Int J Neuropsychopharmacol; 2006 Apr; 9(2):175-89. PubMed ID: 15877932 [TBL] [Abstract][Full Text] [Related]
22. Scopolamine and amphetamine produce similar decision-making deficits on a rat gambling task via independent pathways. Silveira MM; Malcolm E; Shoaib M; Winstanley CA Behav Brain Res; 2015 Mar; 281():86-95. PubMed ID: 25529186 [TBL] [Abstract][Full Text] [Related]
23. Is behavioral sensitization to 3,4-methylenedioxymethamphetamine (MDMA) mediated in part by cholinergic receptors? Lettfuss NY; Seeger-Armbruster S; von Ameln-Mayerhofer A Behav Brain Res; 2013 May; 244():116-9. PubMed ID: 23380677 [TBL] [Abstract][Full Text] [Related]
24. Mecamylamine reverses physostigmine-induced attenuation of scopolamine-induced hyperactivity. O'Neill MF; Fernández AG; Gristwood RW; Palacios JM J Neural Transm Gen Sect; 1994; 96(1):9-18. PubMed ID: 7857593 [TBL] [Abstract][Full Text] [Related]
25. Rapamycin inhibits mTOR/p70S6K activation in CA3 region of the hippocampus of the rat and impairs long term memory. Lana D; Di Russo J; Mello T; Wenk GL; Giovannini MG Neurobiol Learn Mem; 2017 Jan; 137():15-26. PubMed ID: 27838442 [TBL] [Abstract][Full Text] [Related]
26. CDP-choline attenuates scopolamine induced disruption of prepulse inhibition in rats: involvement of central nicotinic mechanism. Uslu G; Savci V; Buyukuysal LR; Goktalay G Neurosci Lett; 2014 May; 569():153-7. PubMed ID: 24708927 [TBL] [Abstract][Full Text] [Related]
27. Nicotinic facilitation of delta9-tetrahydrocannabinol discrimination involves endogenous anandamide. Solinas M; Scherma M; Tanda G; Wertheim CE; Fratta W; Goldberg SR J Pharmacol Exp Ther; 2007 Jun; 321(3):1127-34. PubMed ID: 17351107 [TBL] [Abstract][Full Text] [Related]
33. Comparative behavioral and neurochemical activities of cholinergic antagonists in rats. Bymaster FP; Heath I; Hendrix JC; Shannon HE J Pharmacol Exp Ther; 1993 Oct; 267(1):16-24. PubMed ID: 7901390 [TBL] [Abstract][Full Text] [Related]
34. Huperzine A inhibits immediate addictive behavior but not behavioral sensitization following repeated morphine administration in rats. Sun J; Tian L; Cui R; Li X Exp Ther Med; 2017 Apr; 13(4):1584-1591. PubMed ID: 28413513 [TBL] [Abstract][Full Text] [Related]
35. Cholinergic drugs regulate passive avoidance performance via the amygdala. Riekkinen P; Riekkinen M; Sirviö J J Pharmacol Exp Ther; 1993 Dec; 267(3):1484-92. PubMed ID: 8263810 [TBL] [Abstract][Full Text] [Related]
36. Once weekly administration of nicotine produces long-lasting locomotor sensitization in rats via a nicotinic receptor-mediated mechanism. Miller DK; Wilkins LH; Bardo MT; Crooks PA; Dwoskin LP Psychopharmacology (Berl); 2001 Aug; 156(4):469-76. PubMed ID: 11498725 [TBL] [Abstract][Full Text] [Related]
37. Opposing influences on behavior mediated by muscarinic and nicotinic receptors in the rat posterior hypothalamic nucleus. Buccafusco JJ; Brezenoff HE Psychopharmacology (Berl); 1980; 67(3):249-54. PubMed ID: 6770404 [TBL] [Abstract][Full Text] [Related]
38. Roles of pedunculopontine tegmental cholinergic receptors in brain stimulation reward in the rat. Chen J; Nakamura M; Kawamura T; Takahashi T; Nakahara D Psychopharmacology (Berl); 2006 Mar; 184(3-4):514-22. PubMed ID: 16385418 [TBL] [Abstract][Full Text] [Related]
39. The role of nicotinic and muscarinic acetylcholine receptors in attention. Mirza NR; Stolerman IP Psychopharmacology (Berl); 2000 Feb; 148(3):243-50. PubMed ID: 10755737 [TBL] [Abstract][Full Text] [Related]
40. Involvement of dorsal hippocampal nicotinic receptors in the effect of morphine on memory retrieval in passive avoidance task. Khajehpour L; Rezayof A; Zarrindast MR Eur J Pharmacol; 2008 Apr; 584(2-3):343-51. PubMed ID: 18316071 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]